Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase …
G Plewig, WJ Cunliffe, N Binder, K Höschen - Contraception, 2009 - Elsevier
BACKGROUND: The study was conducted to assess the effects of the monophasic
combined oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone …
combined oral contraceptive containing ethinyl estradiol (EE) 0.03 mg and chlormadinone …
Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara®) and EE/LNG (Microgynon®)
I Worret, W Arp, HP Zahradnik, JO Andreas, N Binder - Dermatology, 2001 - karger.com
Abstract Background and Objective: Acne in women can often be successfully treated by the
intake of oral contraceptives containing gestagens with anti-androgenic properties. This …
intake of oral contraceptives containing gestagens with anti-androgenic properties. This …
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo …
E Palombo-Kinne, I Schellschmidt, U Schumacher… - Contraception, 2009 - Elsevier
BACKGROUND: Acne is a multifactorial disease characterized by androgenic stimulation of
sebaceous glands. Therefore, combined oral contraceptives (COCs) containing anti …
sebaceous glands. Therefore, combined oral contraceptives (COCs) containing anti …
Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate
M Vartiainen, H De Gezelle… - The European Journal of …, 2001 - Taylor & Francis
Objective: To investigate the effect of a combiphasic oral contraceptive containing
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24 …
C Brucker, B Hedon, HS The, K Höschen, N Binder… - Contraception, 2010 - Elsevier
OBJECTIVE: This study was conducted to assess the long-term efficacy and safety of a low-
dose monophasic combined oral contraceptive (COC) containing 0.02 mg ethinylestradiol …
dose monophasic combined oral contraceptive (COC) containing 0.02 mg ethinylestradiol …
Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial
GP Redmond, WH Olson, JS Lippman… - Obstetrics & …, 1997 - Elsevier
OBJECTIVE: To evaluate the efficacy of a triphasic, combination oral contraceptive
(OC),(norgestimate-ethinyl estradiol), in comparison with placebo in the treatment of …
(OC),(norgestimate-ethinyl estradiol), in comparison with placebo in the treatment of …
Treating acne with oral contraceptives: use of lower doses
J Huber, K Walch - Contraception, 2006 - Elsevier
Oral contraceptives (OCs) have been shown to effectively treat acne. Clinical trials of various
doses of ethinyl estradiol (EE) combined with progestins such as levonorgestrel …
doses of ethinyl estradiol (EE) combined with progestins such as levonorgestrel …
[HTML][HTML] A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment
D Thiboutot, DF Archer, A Lemay, K Washenik… - Fertility and sterility, 2001 - Elsevier
Objective: To evaluate the efficacy of a low-dose oral contraceptive (OC) containing 100 μg
of levonorgestrel (LNG) and 20 μg of ethinyl estradiol (EE) compared with placebo for the …
of levonorgestrel (LNG) and 20 μg of ethinyl estradiol (EE) compared with placebo for the …
A randomized controlled trial of second-versus third-generation oral contraceptives in the treatment of acne vulgaris
MP Rosen, DM Breitkopf, M Nagamani - American journal of obstetrics and …, 2003 - Elsevier
Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …
Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a …
W Koltun, JM Maloney, J Marr, M Kunz - European Journal of Obstetrics & …, 2011 - Elsevier
OBJECTIVE: To investigate the effects of an ethinylestradiol (EE) 20μg/drospirenone (drsp)
3mg combined oral contraceptive (COC) administered in a 24/4 regimen (24 active tablets/4 …
3mg combined oral contraceptive (COC) administered in a 24/4 regimen (24 active tablets/4 …